Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001780081-25-000006

Director sold 40,472 shares at $29.72 ($1,202,719)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Krainer Adrian R. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-24 Sale : show line 1 in the form 10b5-1 −40,472 $29.72 $1,202,719 323,774 D
Open-market sales · 40,472 sh · avg $29.72 · $1,202,719
Loading xslF345X05/form4-11262025_091144.xml…